# FL- 101 Study in Non-Metastatic MIBC

> **NCT05395260** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Flame Biosciences**

## Conditions studied

- Muscle Invasive Bladder Carcinoma

## Interventions

- **DRUG:** FL-101

## Key facts

- **NCT ID:** NCT05395260
- **Lead sponsor:** Flame Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08-22
- **Primary completion:** 2022-11-28
- **Final completion:** 2022-12-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor Decision
- **Last updated:** 2022-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05395260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05395260, "FL- 101 Study in Non-Metastatic MIBC". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05395260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*